Med BioGene Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.01913 million compared to USD 0.009082 million a year ago. For the nine months, net loss was USD 0.050396 million compared to USD 0.045512 million a year ago.